SCHEMBL7208217

SCHEMBL7208217

COc1ccc(NC(=O)c2ccccc2NS(=O)(=O)c2ccc(C)cc2)cc1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.59
KMT2A Q03164 6/20 0.59
ALDH1A1 P00352 3/20 0.59
MAPK1 P28482 1/20 0.59
MAPT P10636 5/20 0.58
SMN1; SMN2 Q16637 4/20 0.58
HPGD P15428 4/20 0.58
NPC1 O15118 1/20 0.58
RAB9A P51151 1/20 0.58
THRB P10828 2/20 0.57
HTT P42858 4/20 0.56
LMNA P02545 3/20 0.56
TDP1 Q9NUW8 1/20 0.56
PTK2 Q05397 1/20 0.56
KDM4E B2RXH2 2/20 0.56
PTGDR2 Q9Y5Y4 1/20 0.56
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
CRHBP P24387 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7209352 0.92 AVPR2 (0.59) MEN1KMT2AALDH1A1MAPK1MAPT
SCHEMBL27580344 0.88 KMT2A (0.55) MEN1KMT2AALDH1A1MAPK1MAPT
SCHEMBL23200266 0.83 KDM4E (0.73) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL29834290 0.83 LMNA (0.68) MEN1KMT2AALDH1A1MAPK1MAPT
SCHEMBL23200348 0.83 LMNA (0.68) MEN1KMT2AALDH1A1MAPK1MAPT
SCHEMBL23200273 0.83 LMNA (0.68) MEN1KMT2AALDH1A1MAPK1MAPT
SCHEMBL30257110 0.83 LMNA (0.68) MEN1KMT2AALDH1A1MAPK1MAPT
SCHEMBL23200304 0.82 KMT2A (0.67) MEN1KMT2AALDH1A1MAPK1MAPT
SCHEMBL14267570 0.82 MEN1 (0.73) MEN1KMT2AALDH1A1SMN1; SMN2HPGD
SCHEMBL23200286 0.82 MEN1 (0.67) MEN1KMT2AALDH1A1MAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187531-A4 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2003-05-28 EP disclosed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US disclosed
EP-1187531-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2002-03-20 EP disclosed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO disclosed
WO-2000078145-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-28 WO disclosed